Please use this identifier to cite or link to this item:
|Title:||Clinicopathological significance of calreticulin in breast invasive ductal carcinoma|
invasive ductal breast carcinoma
|Source:||Lwin, Z.-M., Guo, C., Salim, A., Yip, G.W.-C., Chew, F.-T., Nan, J., Thike, A.A., Tan, P.-H., Bay, B.-H. (2010-12). Clinicopathological significance of calreticulin in breast invasive ductal carcinoma. Modern Pathology 23 (12) : 1559-1566. ScholarBank@NUS Repository. https://doi.org/10.1038/modpathol.2010.173|
|Abstract:||Calreticulin is a chaperone protein located in the lumen of the endoplasmic reticulum. The association of calreticulin with pathological conditions such as autoimmune disorders and certain types of cancer have been reported. However, little is known about its role in the pathogenesis of breast cancer. The aim of this study was to determine the expression of calreticulin in vitro and correlate its expression levels in breast cancer tissue samples with clinicopathological parameters. Calreticulin expression was evaluated in MCF-7 and MDA-MB-231 breast cancer cells by real-time RT-PCR, Western blot, immunohistochemistry, and immunofluorescence staining. Patient tissue microarrays were constructed from 228 breast cancer specimens for immunohistochemical analysis. The in vitro study showed a higher calreticulin expression in more aggressive MDA-MB-231 cells as compared with MCF-7 cells at both mRNA and protein levels. In all, 227 out of 228 breast cancer samples exhibited calreticulin staining in at least 5% of the cancer cells. Calreticulin immunostaining was observed to be localized to the cytoplasm of the cancer cells. Regression analysis of calreticulin immunostaining in the tissue microarrays revealed that its expression was positively correlated to logarithm of (log) tumor size (P0.046) and development of distant metastasis (P0.017). Multivariate analysis confirmed calreticulin expression as an independent predictor of log tumor size and occurrence of distant metastasis. The data suggest that calreticulin expression is associated with more advanced tumors and is a potential prognostic biomarker. © 2010 USCAP, Inc. All rights reserved.|
|Source Title:||Modern Pathology|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Dec 13, 2017
WEB OF SCIENCETM
checked on Nov 14, 2017
checked on Dec 9, 2017
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.